Hemokinin-1 activates the MAPK pathway and enhances B cell proliferation and antibody production

Journal of Immunology

Volumn 184, Issue 7, 2010, Pages 3590-3597

  Wang, Wei ^a   Li, Qian ^a   Zhang, Jun ^a   Wu, Hounan ^a   Yin, Yanhui ^a   Ge, Qing ^a   Zhang, Yu ^a  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; B LYMPHOCYTE INDUCED MATURATION PROTEIN 1; B LYMPHOCYTE RECEPTOR; B7 ANTIGEN; CD40 ANTIGEN; CD86 ANTIGEN; HEMOKININ 1; IMMUNOGLOBULIN M; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE; SUBSTANCE P; TACHYKININ; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; X BOX BINDING PROTEIN 1; DNA BINDING PROTEIN; HEMOKININ-1; PRDM1 PROTEIN, MOUSE; REGULATORY FACTOR X TRANSCRIPTION FACTORS;

ANIMAL CELL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; CELL DIFFERENTIATION; CELL SURVIVAL; CONTROLLED STUDY; CROSS LINKING; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; IMMUNOGLOBULIN PRODUCTION; IMMUNOREGULATION; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; SIGNAL TRANSDUCTION; ANIMAL; BIOSYNTHESIS; C3H MOUSE; C57BL MOUSE; CELL PROLIFERATION; CELL SEPARATION; CYTOLOGY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENE EXPRESSION; GENE EXPRESSION REGULATION; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANIMALS; ANTIBODY FORMATION; B-LYMPHOCYTES; BLOTTING, WESTERN; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SEPARATION; CELL SURVIVAL; DNA-BINDING PROTEINS; ENZYME-LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FLOW CYTOMETRY; GENE EXPRESSION; GENE EXPRESSION REGULATION; IMMUNOGLOBULIN M; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TACHYKININS; TRANSCRIPTION FACTORS;

EID: 77951623951     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0901278     Document Type: Article

References (48)

1. LeBien, T. W., and T. F. Tedder. 2008. B lymphocytes: how they develop and function. Blood 112: 1570-1580.
2. McHeyzer-Williams, L. J., L. P. Malherbe, and M. G. McHeyzer-Williams. 2006. Checkpoints in memory B-cell evolution. Immunol. Rev. 211: 255-268.
3. McHeyzer-Williams, L. J., and M. G. McHeyzer-Williams. 2005. Antigen-specific memory B cell development. Annu. Rev. Immunol. 23: 487-513.
4. Shaffer, A. L., X. Yu, Y. S. He, J. Boldrick, E. P. Chan, and L. M. Staudt. 2000. BCL-6 represses genes that function in lymphocyte differentiation, inflammation, and cell cycle control. Immunity 13: 199-212.
5. Shaffer, A. L., K. I. Lin, T. C. Kuo, X. Yu, E. M. Hurt, A. Rosenwald, J. M. Giltnane, L. M. Yang, H. Zhao, K. Calame, and L. M. Staudt. 2002. Blimp-1 orchestrates plasma cell differentiation by extinguishing the mature B cell gene expression program. Immunity 17: 51-62.
6. Lin, K.-I., C. Angelin-Duclos, T. C. Kuo, and K. Calame. 2002. Blimp-1-dependent repression of Pax-5 is required for differentiation of B cells to immunoglobulin M-secreting plasma cells. Mol. Cell. Biol. 22: 4771-4780.
7. Shaffer, A. L., M. Shapiro-Shelef, N. N. Iwakoshi, A. H. Lee, S. B. Qian, H. Zhao, X. Yu, L. M. Yang, B. K. Tan, A. Rosenwald, et al. 2004. XBP1, downstream of Blimp-1, expands the secretory apparatus and other organelles, and increases protein synthesis in plasma cell differentiation. Immunity 21: 81-93.
8. Snapper, C. M., and W. E. Paul. 1987. Interferon-gamma and B cell stimulatory factor-1 reciprocally regulate Ig isotype production. Science 236: 944-947.
9. Cazac, B. B., and J. Roes. 2000. TGF-beta receptor controls B cell responsiveness and induction of IgA in vivo. Immunity 13: 443-451.
10. Bishop, G. A., and B. S. Hostager. 2001. B lymphocyte activation by contact-mediated interactions with T lymphocytes. Curr. Opin. Immunol. 13: 278-285.
11. Quezada, S. A., L. Z. Jarvinen, E. F. Lind, and R. J. Noelle. 2004. CD40/CD154 interactions at the interface of tolerance and immunity. Annu. Rev. Immunol. 22: 307-328.
12. Mackay, F., and J. L. Browning. 2002. BAFF: a fundamental survival factor for B cells. Nat. Rev. Immunol. 2: 465-475.
13. Crowley, J. E., L. S. Treml, J. E. Stadanlick, E. Carpenter, and M. P. Cancro. 2005. Homeostatic niche specification among naïve and activated B cells: a growing role for the BLyS family of receptors and ligands. Semin. Immunol. 17: 193-199.
14. Do, R. K. G., E. Hatada, H. Lee, M. R. Tourigny, D. Hilbert, and S. Chen-Kiang. 2000. Attenuation of apoptosis underlies B lymphocyte stimulator enhancement of humoral immune response. J. Exp. Med. 192: 953-964.
15. Litinskiy, M. B., B. Nardelli, D. M. Hilbert, B. He, A. Schaffer, P. Casali, and A. Cerutti. 2002. DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL. Nat. Immunol. 3: 822-829.
16. Pasare, C., and R. Medzhitov. 2005. Control of B-cell responses by Toll-like receptors. Nature 438: 364-368. (Pubitemid 41643953)
17. Severini, C., G. Improta, G. Falconieri-Erspamer, S. Salvadori, and V. Erspamer. 2002. The tachykinin peptide family. Pharmacol. Rev. 54: 285-322.
18. Harrison, S., and P. Geppetti. 2001. Substance p. Int. J. Biochem. Cell Biol. 33: 555-576.
19. Almeida, T. A., J. Rojo, P. M. Nieto, F. M. Pinto, M. Hernandez, J. D. Martín, and M. L. Candenas. 2004. Tachykinins and tachykinin receptors: structure and activity relationships. Curr. Med. Chem. 11: 2045-2081.
20. Zhang, Y., L. W. Lu, C. Furlonger, G. E. Wu, and C. J. Paige. 2000. Hemokinin is a hematopoietic-specific tachykinin that regulates B lymphopoiesis. Nat. Immunol. 1: 392-397.
21. Duffy, R. A., J. A. Hedrick, G. Randolph, C. A. Morgan, M. E. Cohen-Williams, G. Vassileva, J. E. Lachowicz, M. Laverty, M. Maguire, L. S. Shan, et al. 2003. Centrally administered hemokinin-1 (HK-1), a neurokinin NK1 receptor agonist, produces substance P-like behavioral effects in mice and gerbils. Neuropharmacology 45: 242-250.
22. Morteau, O., B. Lu, C. Gerard, and N. P. Gerard. 2001. Hemokinin 1 is a full agonist at the substance P receptor. Nat. Immunol. 2: 1088.
23. Berger, A., and C. J. Paige. 2005. Hemokinin-1 has Substance P-like function in U-251 MG astrocytoma cells: a pharmacological and functional study. J. Neuroimmunol. 164: 48-56. (Pubitemid 40826762)
24. Page, N. M., N. J. Bell, S. M. Gardiner, I. T. Manyonda, K. J. Brayley, P. G. Strange, and P. J. Lowry. 2003. Characterization of the endokinins: human tachykinins with cardiovascular activity. Proc. Natl. Acad. Sci. USA 100: 6245-6250.
25. Bellucci, F., F. Carini, C. Catalani, P. Cucchi, A. Lecci, S. Meini, R. Patacchini, L. Quartara, R. Ricci, M. Tramontana, et al. 2002. Pharmacological profile of the novel mammalian tachykinin, hemokinin 1. Br. J. Pharmacol. 135: 266-274.
26. Camarda, V., A. Rizzi, G. Calo, R. Guerrini, S. Salvadori, and D. Regoli. 2002. Pharmacological profile of hemokinin 1: a novel member of the tachykinin family. Life Sci. 71: 363-370. (Pubitemid 34607301)
27. Kurtz, M. M., R. P. Wang, M. K. Clements, M. A. Cascieri, C. P. Austin, B. R. Cunningham, G. G. Chicchi, and Q. Y. Liu. 2002. Identification, localization and receptor characterization of novel mammalian substance P-like peptides. Gene 296: 205-212.
28. Tran, A. H., A. Berger, G. E. Wu, and C. J. Paige. 2009. Regulatory mechanisms in the differential expression of Hemokinin-1. Neuropeptides 43: 1-12.
29. Page, N. M. 2004. Hemokinins and endokinins. Cell. Mol. Life Sci. 61: 1652-1663.
30. Zhang, Y., and C. J. Paige. 2003. T-cell developmental blockage by tachykinin antagonists and the role of hemokinin 1 in T lymphopoiesis. Blood 102: 2165-2172. (Pubitemid 37122394)
31. Wang, H. S., and S. H. Clarke. 2007. Association of the pre-B cell receptor (BCR) expression level with the quality of pre-BII cell differentiation reveals hierarchical pre-BCR function. Mol. Immunol. 44: 1765-1774.
32. Rui, L. X., J. I. Healy, J. Blasioli, and C. C. Goodnow. 2006. ERK signaling is a molecular switch integrating opposing inputs from B cell receptor and T cell cytokines to control TLR4-driven plasma cell differentiation. J. Immunol. 177: 5337-5346.
33. Calame, K. L., K. I. Lin, and C. Tunyaplin. 2003. Regulatory mechanisms that determine the development and function of plasma cells. Annu. Rev. Immunol. 21: 205-230.
34. Berger, A., A. H. Tran, and C. J. Paige. 2007. Co-regulated decrease of Neurokinin-1 receptor and Hemokinin-1 gene expression in monocytes and macrophages after activation with pro-inflammatory cytokines. J. Neuroimmunol. 187: 83-93. (Pubitemid 47008930)
35. Dal Porto, J. M., S. B. Gauld, K. T. Merrell, D. Mills, A. E. Pugh-Bernard, and J. Cambier. 2004. B cell antigen receptor signaling 101. Mol. Immunol. 41: 599-613.
36. Oh-hora, M., and A. Rao. 2008. Calcium signaling in lymphocytes. Curr. Opin. Immunol. 20: 250-258.
37. Cullen, P. J., and P. J. Lockyer. 2002. Integration of calcium and Ras signalling. Nat. Rev. Mol. Cell Biol. 3: 339-348.
38. Maggi, C. A. 1997. The effects of tachykinins on inflammatory and immune cells. Regul. Pept. 70: 75-90.
39. O'Connor, T. M., J. O'Connell, D. I. O'Brien, T. Goode, C. P. Bredin, and F. Shanahan. 2004. The role of substance P in inflammatory disease. J. Cell. Physiol. 201: 167-180.
40. Nelson, D. A., and K. L. Bost. 2004. Non-neuronal mammalian tachykinin expression. Front. Biosci. 9: 2166-2176.
41. Zhang, Y., A. Berger, C. D. Milne, and C. J. Paige. 2006. Tachykinins in the immune system. Curr. Drug Targets 7: 1011-1020.
42. Metwali, A., A. M. Blum, D. E. Elliott, T. Setiawan, and J. V. Weinstock. 2004. Cutting edge: hemokinin has substance P-like function and expression in inflammation. J. Immunol. 172: 6528-6532. (Pubitemid 38669085)
43. Janelsins, B. M., A. R. Mathers, O. A. Tkacheva, G. Erdos, W. J. Shufesky, A. E. Morelli, and A. T. Larregina. 2009. Proinflammatory tachykinins that signal through the neurokinin 1 receptor promote survival of dendritic cells and potent cellular immunity. Blood 113: 3017-3026.
44. Bost, K. L., and D. W. Pascual. 1992. Substance P: a late-acting B lymphocyte differentiation cofactor. Am. J. Physiol. 262: C537-C545.
45. Nelson, D. A., I. Marriott, and K. L. Bost. 2004. Expression of hemokinin 1 mRNA by murine dendritic cells. J. Neuroimmunol. 155: 94-102. (Pubitemid 39165781)
46. Moriyama, M., T. Yamochi, K. Semba, T. Akiyama, and S. Mori. 1997. BCL-6 is phosphorylated at multiple sites in its serine- and proline-clustered region by mitogen-activated protein kinase (MAPK) in vivo. Oncogene 14: 2465-2474. (Pubitemid 27268165)
47. Niu, H. F., B. H. H. Ye, and R. Dalla-Favera. 1998. Antigen receptor signaling induces MAP kinase-mediated phosphorylation and degradation of the BCL-6 transcription factor. Genes Dev. 12: 1953-1961.
48. Sun, J., R. D. Ramnath, R. Tamizhselvi, and M. Bhatia. 2009. Role of protein kinase C and phosphoinositide 3-kinase-Akt in substance P-induced proinflammatory pathways in mouse macrophages. FASEB J. 23: 997-1010.